Healthcare costs of fast-acting insulin analogues vs. short-acting human insulin in combination with long-acting insulin analogues for Danish patients with type 2 diabetes

被引：0
|
作者：
Gundgaard, J. [1 ]
Christensen, T. [2 ]
Thomsen, T. [2 ]
机构：
[1] COWI AS, Hlth & Econ, Kongens Lyngby, Denmark
[2] Novo Nordisk AS, Virum, Denmark
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1061
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Fast-Acting Insulin Aspart and the Need for New Mealtime Insulin Analogues in Adults With Type 1 and Type 2 Diabetes: A Canadian Perspective
    Senior, Peter
    Hramiak, Irene
    CANADIAN JOURNAL OF DIABETES, 2019, 43 (07) : 515 - 523
  • [42] Cost-effectiveness of long-acting insulin analogues vs intermediate/long-acting human insulin for type 1 diabetes: A population-based cohort followed over 10 years
    Lee, Tsung-Ying
    Kuo, Shihchen
    Yang, Chen-Yi
    Ou, Huang-Tz
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (05) : 852 - 860
  • [43] The significance of long acting insulin analogues in the treatment of type 2 diabetes mellitus
    Ludvik, Bernhard
    Brath, Helmut
    Wascher, Thomas
    Toplak, Hermann
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (13-14) : 473 - 482
  • [44] (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus
    Hemmingsen, Bianca
    Metzendorf, Maria-Inti
    Richter, Bernd
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (03):
  • [45] Revisiting short-acting insulin analogues.: In obese subjects with type 2 diabetes, are they short?: A pharmacokinetics study
    Gagnon-Auger, M.
    Baillargeon, J.-P.
    Menard, J.
    Brassard, P.
    Martin, E.
    Ardilouze, J.-L.
    DIABETOLOGIA, 2007, 50 : S26 - S26
  • [46] Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus
    Plank, J
    Siebenhofer, A
    Berghold, A
    Jeitler, K
    Horvath, K
    Mrak, P
    Pieber, TR
    ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (12) : 1337 - 1344
  • [47] Subcutaneous fast-acting insulin analogues, alone or in combination with long-acting insulin, versus intravenous regular insulin infusion in patients with diabetic ketoacidosis: protocol for an updated systematic review and meta-analysis of randomised trials
    Lim, Beng Leong
    Lee, Wei Feng
    Lee, Berlin
    Chung, Yan Ee Lynette
    Loo, Kee Vooi
    BMJ OPEN, 2023, 13 (02):
  • [48] LIGHT study: initiation of long-acting insulin analogues in elderly type 2 diabetic patients
    Doucet, I.
    Kerlan, V.
    Verges, B.
    Tawil, C.
    Alexandre, B.
    Brun, J. M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 69 - 69
  • [49] Insulin analogues (insulin detemir and insulin aspart) in comparison with traditional human insulin (NPH-insulin and short-acting human insulin) in basal bolus therapy of type 1 diabetes mellitus
    Khermansen, K.
    Fonten, P.
    Kukolyya, K. K.
    Peterkova, V. A.
    Leyt, G.
    Gall, M.
    DIABETES MELLITUS, 2006, 9 (01): : 18 - 26
  • [50] Solution structures of long-acting insulin analogues and their complexes with albumin
    Ryberg, Line A.
    Sonderby, Pernille
    Barrientos, Fabian
    Bukrinski, Jens T.
    Peters, Gunther H. J.
    Harris, Pernille
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2019, 75 : 272 - 282
12345